Novo Nordisk A/S

Novo Nordisk A/S

Verified
Global healthcare company with 95 years of innovation and leadership in diabetes care
Bagsværd Capital Region of Denmark (HQ)
Deals in the last 12 months undisclosed
Corporate Venture Fund: Novo Ventures, Novo Holdings

Company information

Edit
Launch date
Employees
Market cap
DKK1.4t
Net debt
DKK459.0b
Firm valuation
$212.0b (Public information from 2022)
Revenues, earnings & profits over time
EUR201620172018201920202021E2022E
Revenues-14.9b14.9b16.3b16.9b18.6b20.5b
% growth---9 %4 %10 %10 %
EBITDA-7.0b6.8b7.8b8.0b8.7b9.6b
% EBITDA margin-47 %46 %48 %47 %47 %47 %
Profit-5.1b5.2b5.2b5.6b6.3b6.7b
% profit margin-34 %35 %32 %33 %34 %33 %
EV / revenue-7.2x6.2x7.4x7.8x10.3x9.4x
EV / EBITDA-15.4x13.6x15.5x16.4x22.1x20.0x
R&D budget2.0b1.9b1.8b1.7b---
R&D % of revenue-13 %12 %11 %---

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
N/AN/AIPO
Not yet verified
Total Funding-

Recent News about Novo Nordisk A/S

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit